The FDA has determined that the nationwide shortage of semaglutide injection, used for both diabetes and weight loss, is resolved after more than two years of limited availability due to high demand.
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
The Food and Drug Administration said on Friday that the shortage of semaglutide injection products, such as Novo Nordisk's Wegovy, has been resolved. FDA's update led to renewed uncertainty for a ...
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
In recent months, the efficacy of contraception for people taking weight loss medications has been questioned, as several women claim to have gotten pregnant despite using oral contraceptives.
President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy of the weight-loss medicines it mailed to patients.
A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback